Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate Tablet
Product Images NDC 58118-1189

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate (NDC 58118-1189). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinical Solutions Wholesale, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine/naloxone 2/0.5mg Tablets 30ct Blister Card (Image 01)

Packaging label for buprenorphine hydrochloride and naloxone hydrochloride dihydrate sublingual tablets, strength 2 mg/0.5 mg, supplied in a quantity of 30 tablets. The label shows the product name as Buprenorphine/Naloxone 2/0.5 mg and is labeled by Clinical Solutions Wholesale, LLC. It includes manufacturing details from Hikma Pharmaceuticals USA in Eatontown, NJ, along with NDC 58118-1188-8 and lot number SAMPLE123.*

FDA Label Image

Buprenorphine-chem-structure.jpg (Image 02)

Chemical structure diagram of buprenorphine hydrochloride and naloxone hydrochloride dihydrate, showing molecular bonds and functional groups for the active ingredient buprenorphine hydrochloride.*

FDA Label Image

Bupr-naloxone-ifu-mouth-image (Image 03)

An instructional diagram depicting a person placing a sublingual tablet under the tongue. The image shows an open mouth with visible teeth and tongue, illustrating the correct placement location for the tablet.*

FDA Label Image

Naloxone-chem-structure.jpg (Image 04)

Chemical structure of buprenorphine hydrochloride and naloxone hydrochloride dihydrate, showing the molecular framework with functional groups and hydrate notation.*

FDA Label Image

Buprenorphine/naloxone 8/2mg Tablets 30ct Blister Card (Image 05)

Packaging label for buprenorphine hydrochloride and naloxone hydrochloride dihydrate sublingual tablets, strength 8 mg/2 mg. The label displays Clinical Solutions Wholesale as the labeler, includes the NDC 58118-1189-8, quantity of 30 tablets, manufacturer Hikma Pharmaceuticals USA, and batch information along with a QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.